Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy

Ariela Benigni; Carla Zoja; Cristina Zatelli; Daniela Corna; Lorena Longaretti; Daniela Rottoli; Paola Maggioni; Marta Todeschini; Marina Noris; Giuseppe Remuzzi

doi:10.1111/j.1523-1755.2004.00982.x

Related publications

Article2003

Add-On Anti–TGF-β Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat

Ariela Benigni, Carla Zoja, Daniela Corna, Cristina Zatelli, Sara Conti, Marco Campana, Elena Gagliardini, Daniela Rottoli, Cristina Zanchi, Mauro Abbate, Steve Ledbetter, Giuseppe Remuzzi

Article2016

A previously unrecognized role of C3a in proteinuric progressive nephropathy

Marina Morigi, Monica Locatelli, Cinzia Rota, Simona Buelli, Daniela Corna, Paola Rizzo, Mauro Abbate, Debora Conti, Luca Perico, Lorena Longaretti, Ariela Benigni, Carla Zoja, Giuseppe Remuzzi

Article2002

How To Fully Protect the Kidney in a Severe Model of Progressive Nephropathy

Carla Zoja, Daniela Corna, Davide Camozzi, Dario Cattaneo, Daniela Rottoli, Cristian Batani, Cristina Zanchi, Mauro Abbate, Giuseppe Remuzzi

Article2002

Effect of combining ACE inhibitor and statin in severe experimental nephropathy

Carla Zoja, Daniela Corna, Daniela Rottoli, Dario Cattaneo, Cristina Zanchi, Susanna Tomasoni, Mauro Abbate, Giuseppe Remuzzi

Article2018

SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy

Paola Cassis, Monica Locatelli, Domenico Cerullo, Daniela Corna, Simona Buelli, Cristina Zanchi, Sebastian Villa, Marina Morigi, Giuseppe Remuzzi, Ariela Benigni, Carla Zoja